GLYCOpyrrolate
Lack of Assurance of Sterility
Yes — there is an active recall. 5 ongoing FDA recalls mention Glycopyrrolate (49 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Glycopyrrolate. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of sterility assurance.
Lack of sterility assurance.
Lack of Sterility Assurance.
Lack of Sterility Assurance.
Lack of Sterility Assurance.
Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.
Stability data does not support expiry.
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
Labeling: Incorrect or missing Lot and/or Exp Date: Printing error caused an overlap in the "y" and "3" making the actual "Use By 3/2015" date appear to read "Use By8/2015".
Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.
Non-Sterility: One lot of Glycopyrrolate solution for injection was found to be contaminated with Bacillus thuringiensis.
Labeling: Label Mixup: GLYCOPYRROLATE, Tablet, 2 mg may have potentially been mislabeled as one of the following drugs: PARICALCITOL, Capsule, 1 mcg, NDC 00074431730, Pedigree: W002667, EXP: 6/5/2014; guaiFENesin ER, Tablet, 600 mg, NDC 63824000850, Pedigree: W003244, EXP: 6/17/2014; LACTOBACILLUS, Tablet, 0, NDC 64980012950, Pedigree: AD22865_1, EXP: 5/2/2014.
Labeling: Label Mixup; GLYCOPYRROLATE Tablet, 2 mg may be potentially mislabeled as LACTOBACILLUS, Tablet, NDC 64980012950, Pedigree: W003624, EXP: 1/31/2014.
Subpotent Drug
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.